Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Breast Cancer (Dove Medical Press)|April 15, 2026
Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast CancerBaha Sharaf, Alaa Seif, Hira Bani Hani, et al.
Breast Cancer (Dove Medical Press)|January 20, 2023
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast CancerHikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, et al.
Frontiers in Oncology|June 5, 2026
Precise radiation, better airway preservation: vocal cord-only image-guided intensity-modulated radiation therapy for early-stage glottic cancerIssa Mohamad, Ibrahim Alotain, Shatha Abu Taha, et al.
Immunotargets and Therapy|October 4, 2024
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced CountryHikmat Abdel-Razeq, Baha Sharaf, Suhaib Khater, et al.
Frontiers in Immunology|September 17, 2024
The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysisAkram Al-Ibraheem, Ahmed Saad Abdlkadir, Dhuha Ali Al-Adhami, et al.
Breast Cancer Research and Treatment|March 17, 2021
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXESYoung-Hyuck Im, Bulent Karabulut, Keun Seok Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2024
Clinical Characteristics and Outcomes of CML in Adolescents and Young AdultsKamal Al-Rabi, Mohammad Ma'koseh, Fadwa Al-Qadi, et al.
The Lancet. Oncology|January 22, 2026
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trialLisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, et al.
Cancers|June 19, 2024
From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate CancerAkram Al-Ibraheem, Ahmed Saad Abdlkadir, Deya' Aldeen Sweedat, et al.
JCO Global Oncology|June 6, 2024
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics StudyHikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, et al.
Pageof 17